Login / Signup

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.

Disha MalaniBhagwan YadavAshwini KumarSwapnil PotdarMika KontroMatti KankainenKomal K JavarappaKimmo PorkkaMaija WolfTero AittokallioKrister WennerbergCaroline A HeckmanAstrid MurumägiOlli Kallioniemi
Published in: Leukemia (2020)
Keyphrases
  • poor prognosis
  • cell proliferation
  • signaling pathway
  • chronic myeloid leukemia